Insecticides (India) Ltd (NSE:INSECTICID)
₹ 647.7 -2.95 (-0.45%) Market Cap: 18.77 Bil Enterprise Value: 19.42 Bil PE Ratio: 13.46 PB Ratio: 1.54 GF Score: 91/100

Q1 2025 Insecticides (India) Ltd Earnings Call Transcript

Aug 09, 2024 / 11:30AM GMT
Release Date Price: ₹910.65 (+6.61%)

Key Points

Positve
  • Revenue from operations increased to INR657 crore in Q1 FY25 from INR640 crore in Q1 FY24.
  • EBITDA saw a significant rise to INR72 crore in Q1 FY25 from INR46 crore in Q1 FY24.
  • PAT improved to INR49 crore in Q1 FY25 from INR29 crore in Q1 FY24.
  • Premium products contributed 60% to the total B2C sales, indicating a successful focus on premiumization.
  • Volume growth of 15% was achieved in Q1 FY25, showcasing strong demand and operational efficiency.
Negative
  • B2B sales faced challenges with achieving value growth despite maintaining volume.
  • International market conditions remain challenging due to geopolitical issues and currency devaluation.
  • High inventory levels at the end of Q1, touching around INR700 crore, though expected to reduce.
  • Dependence on regulatory approvals for new plant operations, causing delays in production commencement.
  • Generic products continue to contribute lower margins, around 12% to 15%, compared to premium products.
Operator

Ladies and gentlemen, good day, and welcome to the Insecticides (India) Limited Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Bhavya Shah. Thank you, and over to you.

Bhavya Shah;Rajesh Aggarwal;India;Ltd;Managing Director
Orient Capital - Investor Relations;Insecticides;Executive Director

Thank you. Good evening, everybody, and welcome to the Q1 FY25 earnings conference call of Insecticides (India) Limited. Today on this call, we have with us Mr. Rajesh Aggarwal, Managing Director; and Mr. Sandeep Aggarwal, Chief Financial Officer.

Before we proceed with this call, I would like to give a small disclaimer that this conference call may contain certain forward-looking statements, which are based on beliefs, opinion and expectation of a company as of date. Now I would like to hand over the call to Mr. Rajesh Aggarwal for his opening remarks. Over to you, sir.

- ()

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot